Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands |
Total |
Cumulative Effect, Period of Adoption, Adjusted Balance |
Common Stock |
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
|
Additional paid-in capital |
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjusted Balance
|
Accumulated Other Comprehensive Loss |
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjusted Balance
|
Accumulated Deficit |
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
|
Beginning balance of common stock (in shares) at Dec. 31, 2020 |
|
|
30,281,520
|
|
|
|
|
|
|
|
Beginning balance of stockholders' equity at Dec. 31, 2020 |
$ 16,496
|
|
$ 3
|
|
$ 135,616
|
|
$ (1,562)
|
|
$ (117,561)
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
(896)
|
|
|
|
|
|
(896)
|
|
|
|
Share-based compensation |
315
|
|
|
|
315
|
|
|
|
|
|
Net loss |
(1,999)
|
|
|
|
|
|
|
|
(1,999)
|
|
Ending balance of common stock (in shares) at Mar. 31, 2021 |
|
|
30,281,520
|
|
|
|
|
|
|
|
Ending balance of stockholders' equity at Mar. 31, 2021 |
6,523
|
|
$ 3
|
|
128,538
|
|
(2,458)
|
|
(119,560)
|
|
Beginning balance of common stock (in shares) at Dec. 31, 2020 |
|
|
30,281,520
|
|
|
|
|
|
|
|
Beginning balance of stockholders' equity at Dec. 31, 2020 |
16,496
|
|
$ 3
|
|
135,616
|
|
(1,562)
|
|
(117,561)
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
(478)
|
|
|
|
|
|
|
|
|
|
Net loss |
(8,201)
|
|
|
|
|
|
|
|
|
|
Ending balance of common stock (in shares) at Jun. 30, 2021 |
|
|
30,281,520
|
|
|
|
|
|
|
|
Ending balance of stockholders' equity at Jun. 30, 2021 |
(6,478)
|
|
$ 3
|
|
121,321
|
|
(2,040)
|
|
(125,762)
|
|
Beginning balance of common stock (in shares) at Dec. 31, 2020 |
|
|
30,281,520
|
|
|
|
|
|
|
|
Beginning balance of stockholders' equity at Dec. 31, 2020 |
16,496
|
|
$ 3
|
|
135,616
|
|
(1,562)
|
|
(117,561)
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
(1,733)
|
|
|
|
|
|
|
|
|
|
Net loss |
$ (12,574)
|
|
|
|
|
|
|
|
|
|
Ending balance of common stock (in shares) at Sep. 30, 2021 |
71,810,419
|
|
71,827,317
|
|
|
|
|
|
|
|
Ending balance of stockholders' equity at Sep. 30, 2021 |
$ 279,562
|
|
$ 7
|
|
412,985
|
|
(3,295)
|
|
(130,135)
|
|
Beginning balance of common stock (in shares) at Dec. 31, 2020 |
|
|
30,281,520
|
|
|
|
|
|
|
|
Beginning balance of stockholders' equity at Dec. 31, 2020 |
16,496
|
|
$ 3
|
|
135,616
|
|
(1,562)
|
|
(117,561)
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
(1,901)
|
|
|
|
|
|
(1,901)
|
|
|
|
Share-based compensation |
(1,856)
|
|
|
|
(1,856)
|
|
|
|
|
|
Net loss |
$ (24,776)
|
|
|
|
|
|
|
|
(24,776)
|
|
Ending balance of common stock (in shares) at Dec. 31, 2021 |
72,027,743
|
|
72,027,743
|
72,027,743
|
|
|
|
|
|
|
Ending balance of stockholders' equity at Dec. 31, 2021 |
$ 267,522
|
$ 256,208
|
$ 7
|
$ 7
|
413,315
|
$ 401,702
|
(3,463)
|
$ (3,463)
|
(142,337)
|
$ (142,038)
|
Beginning balance of common stock (in shares) at Mar. 31, 2021 |
|
|
30,281,520
|
|
|
|
|
|
|
|
Beginning balance of stockholders' equity at Mar. 31, 2021 |
6,523
|
|
$ 3
|
|
128,538
|
|
(2,458)
|
|
(119,560)
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
418
|
|
|
|
|
|
418
|
|
|
|
Share-based compensation |
315
|
|
|
|
315
|
|
|
|
|
|
Net loss |
(6,202)
|
|
|
|
|
|
|
|
(6,202)
|
|
Ending balance of common stock (in shares) at Jun. 30, 2021 |
|
|
30,281,520
|
|
|
|
|
|
|
|
Ending balance of stockholders' equity at Jun. 30, 2021 |
(6,478)
|
|
$ 3
|
|
121,321
|
|
(2,040)
|
|
(125,762)
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
(1,255)
|
|
|
|
|
|
(1,255)
|
|
|
|
Share-based compensation |
(3,519)
|
|
|
|
(3,519)
|
|
|
|
|
|
Net loss |
$ (4,373)
|
|
|
|
|
|
|
|
(4,373)
|
|
Ending balance of common stock (in shares) at Sep. 30, 2021 |
71,810,419
|
|
71,827,317
|
|
|
|
|
|
|
|
Ending balance of stockholders' equity at Sep. 30, 2021 |
$ 279,562
|
|
$ 7
|
|
412,985
|
|
(3,295)
|
|
(130,135)
|
|
Beginning balance of common stock (in shares) at Dec. 31, 2021 |
72,027,743
|
|
72,027,743
|
72,027,743
|
|
|
|
|
|
|
Beginning balance of stockholders' equity at Dec. 31, 2021 |
$ 267,522
|
256,208
|
$ 7
|
$ 7
|
413,315
|
401,702
|
(3,463)
|
(3,463)
|
(142,337)
|
(142,038)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
(123)
|
|
|
|
|
|
(123)
|
|
|
|
Share-based compensation |
2,050
|
|
|
|
2,050
|
|
|
|
|
|
Common stock issued pursuant to acquisition (in shares) |
|
|
4,212,246
|
|
|
|
|
|
|
|
Common stock issued pursuant to acquisition |
23,295
|
|
$ 1
|
|
23,294
|
|
|
|
|
|
Net loss |
(11,572)
|
|
|
|
|
|
|
|
(11,572)
|
|
Ending balance of common stock (in shares) at Mar. 31, 2022 |
|
|
76,239,989
|
|
|
|
|
|
|
|
Ending balance of stockholders' equity at Mar. 31, 2022 |
$ 269,858
|
|
$ 8
|
|
427,046
|
|
(3,586)
|
|
(153,610)
|
|
Beginning balance of common stock (in shares) at Dec. 31, 2021 |
72,027,743
|
|
72,027,743
|
72,027,743
|
|
|
|
|
|
|
Beginning balance of stockholders' equity at Dec. 31, 2021 |
$ 267,522
|
256,208
|
$ 7
|
$ 7
|
413,315
|
401,702
|
(3,463)
|
(3,463)
|
(142,337)
|
(142,038)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
(2,496)
|
|
|
|
|
|
|
|
|
|
Net loss |
(22,362)
|
|
|
|
|
|
|
|
|
|
Ending balance of common stock (in shares) at Jun. 30, 2022 |
|
|
76,239,989
|
|
|
|
|
|
|
|
Ending balance of stockholders' equity at Jun. 30, 2022 |
$ 259,196
|
|
$ 8
|
|
429,547
|
|
(5,959)
|
|
(164,400)
|
|
Beginning balance of common stock (in shares) at Dec. 31, 2021 |
72,027,743
|
|
72,027,743
|
72,027,743
|
|
|
|
|
|
|
Beginning balance of stockholders' equity at Dec. 31, 2021 |
$ 267,522
|
256,208
|
$ 7
|
$ 7
|
413,315
|
401,702
|
(3,463)
|
(3,463)
|
(142,337)
|
(142,038)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
(4,711)
|
|
|
|
|
|
|
|
|
|
Net loss |
(36,639)
|
|
|
|
|
|
|
|
|
|
Ending balance of common stock (in shares) at Sep. 30, 2022 |
|
|
76,292,241
|
|
|
|
|
|
|
|
Ending balance of stockholders' equity at Sep. 30, 2022 |
$ 245,723
|
|
$ 8
|
|
432,566
|
|
(8,174)
|
|
(178,677)
|
|
Beginning balance of common stock (in shares) at Dec. 31, 2021 |
72,027,743
|
|
72,027,743
|
72,027,743
|
|
|
|
|
|
|
Beginning balance of stockholders' equity at Dec. 31, 2021 |
$ 267,522
|
$ 256,208
|
$ 7
|
$ 7
|
413,315
|
$ 401,702
|
(3,463)
|
$ (3,463)
|
(142,337)
|
$ (142,038)
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
(2,927)
|
|
|
|
|
|
(2,927)
|
|
|
|
Share-based compensation |
10,296
|
|
|
|
10,296
|
|
|
|
|
|
Common stock issued pursuant to acquisition (in shares) |
|
|
4,212,246
|
|
|
|
|
|
|
|
Common stock issued pursuant to acquisition |
23,295
|
|
$ 1
|
|
23,294
|
|
|
|
|
|
Net loss |
$ (106,200)
|
|
|
|
|
|
|
|
(106,200)
|
|
Ending balance of common stock (in shares) at Dec. 31, 2022 |
76,292,241
|
|
76,292,241
|
|
|
|
|
|
|
|
Ending balance of stockholders' equity at Dec. 31, 2022 |
$ 180,672
|
|
$ 8
|
|
435,292
|
|
(6,390)
|
|
(248,238)
|
|
Beginning balance of common stock (in shares) at Mar. 31, 2022 |
|
|
76,239,989
|
|
|
|
|
|
|
|
Beginning balance of stockholders' equity at Mar. 31, 2022 |
269,858
|
|
$ 8
|
|
427,046
|
|
(3,586)
|
|
(153,610)
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
(2,373)
|
|
|
|
|
|
(2,373)
|
|
|
|
Share-based compensation |
2,501
|
|
|
|
2,501
|
|
|
|
|
|
Net loss |
(10,790)
|
|
|
|
|
|
|
|
(10,790)
|
|
Ending balance of common stock (in shares) at Jun. 30, 2022 |
|
|
76,239,989
|
|
|
|
|
|
|
|
Ending balance of stockholders' equity at Jun. 30, 2022 |
259,196
|
|
$ 8
|
|
429,547
|
|
(5,959)
|
|
(164,400)
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
(2,215)
|
|
|
|
|
|
(2,215)
|
|
|
|
Share-based compensation |
3,019
|
|
|
|
3,019
|
|
|
|
|
|
Net loss |
(14,277)
|
|
|
|
|
|
|
|
(14,277)
|
|
Ending balance of common stock (in shares) at Sep. 30, 2022 |
|
|
76,292,241
|
|
|
|
|
|
|
|
Ending balance of stockholders' equity at Sep. 30, 2022 |
$ 245,723
|
|
$ 8
|
|
432,566
|
|
(8,174)
|
|
(178,677)
|
|
Beginning balance of common stock (in shares) at Dec. 31, 2022 |
76,292,241
|
|
76,292,241
|
|
|
|
|
|
|
|
Beginning balance of stockholders' equity at Dec. 31, 2022 |
$ 180,672
|
|
$ 8
|
|
435,292
|
|
(6,390)
|
|
(248,238)
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
128
|
|
|
|
|
|
128
|
|
|
|
Share-based compensation |
2,570
|
|
|
|
2,570
|
|
|
|
|
|
Vesting of restricted stock units (in shares) |
|
|
395,067
|
|
|
|
|
|
|
|
Shares withheld related to net share settlement (in shares) |
|
|
(134,713)
|
|
|
|
|
|
|
|
Shares withheld related to net share settlement |
(185)
|
|
|
|
(185)
|
|
|
|
|
|
Net loss |
$ (18,490)
|
|
|
|
|
|
|
|
(18,490)
|
|
Ending balance of common stock (in shares) at Mar. 31, 2023 |
76,552,595
|
|
76,552,595
|
|
|
|
|
|
|
|
Ending balance of stockholders' equity at Mar. 31, 2023 |
$ 164,695
|
|
$ 8
|
|
$ 437,677
|
|
$ (6,262)
|
|
$ (266,728)
|
|